no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies
|
Kong, Melissa H. |
|
2010 |
160 |
4 |
p. 605-618.e1 5576 p. |
article |
2 |
Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis
|
Goldberger, Zachary D. |
|
2010 |
160 |
4 |
p. 701-714 14 p. |
article |
3 |
Association of ST2 levels with cardiac structure and function and mortality in outpatients
|
Daniels, Lori B. |
|
2010 |
160 |
4 |
p. 721-728 8 p. |
article |
4 |
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])
|
Carson, Peter |
|
2010 |
160 |
4 |
p. 649-654 6 p. |
article |
5 |
Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: A Cardiac Safety Research Consortium “Incubator” Think Tank
|
Al-Khatib, Sana M. |
|
2010 |
160 |
4 |
p. 619-626.e1 5642 p. |
article |
6 |
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial
|
Toma, Mustafa |
|
2010 |
160 |
4 |
p. 671-677 7 p. |
article |
7 |
Do heart failure trials need an end point committee?
|
Ghali, Jalal K. |
|
2010 |
160 |
4 |
p. 571-573 3 p. |
article |
8 |
Dronedarone and vitamin K antagonists: A review of drug-drug interactions
|
Shirolkar, Shailesh C. |
|
2010 |
160 |
4 |
p. 577-582 6 p. |
article |
9 |
Editorial Board
|
|
|
2010 |
160 |
4 |
p. A5- 1 p. |
article |
10 |
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia
|
Jones, Peter H. |
|
2010 |
160 |
4 |
p. 759-766 8 p. |
article |
11 |
Electrocardiographic assessment for therapeutic proteins—scientific discussion
|
Rodriguez, Ignacio |
|
2010 |
160 |
4 |
p. 627-634 8 p. |
article |
12 |
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
|
Ruff, Christian T. |
|
2010 |
160 |
4 |
p. 635-641.e2 63466 p. |
article |
13 |
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: Insights from the GUSTO-III trial
|
Tackett, Andrea H. |
|
2010 |
160 |
4 |
p. 678-684 7 p. |
article |
14 |
Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: Results from an observational registry
|
Reynolds, Matthew R. |
|
2010 |
160 |
4 |
p. 752-758 7 p. |
article |
15 |
Impact of prenatal diagnosis and anatomical subtype on outcome in double outlet right ventricle
|
Lagopoulos, Maria E. |
|
2010 |
160 |
4 |
p. 692-700 9 p. |
article |
16 |
Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis
|
Naito, Yoshiro |
|
2010 |
160 |
4 |
p. 685-691 7 p. |
article |
17 |
Information for Readers
|
|
|
2010 |
160 |
4 |
p. A6- 1 p. |
article |
18 |
International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences
|
Lotrionte, Marzia |
|
2010 |
160 |
4 |
p. 662-670 9 p. |
article |
19 |
Is screening cardiac inpatients for depression really feasible?
|
Sowden, Gillian |
|
2010 |
160 |
4 |
p. e31- 1 p. |
article |
20 |
Is screening cardiac inpatients for depression really feasible?
|
Hasnain, Mehrul |
|
2010 |
160 |
4 |
p. e29- 1 p. |
article |
21 |
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease
|
Khan, Abigail May |
|
2010 |
160 |
4 |
p. 715-720 6 p. |
article |
22 |
Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy
|
Bertini, Matteo |
|
2010 |
160 |
4 |
p. 729-736 8 p. |
article |
23 |
Novel antiplatelet therapy
|
Gaglia Jr., Michael A. |
|
2010 |
160 |
4 |
p. 595-604 10 p. |
article |
24 |
Novel biomarkers in cardiovascular disease: Update 2010
|
Hochholzer, Willibald |
|
2010 |
160 |
4 |
p. 583-594 12 p. |
article |
25 |
Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy
|
Auger, Dominique |
|
2010 |
160 |
4 |
p. 737-743 7 p. |
article |
26 |
Racial differences in long-term survival among patients with coronary artery disease
|
Thomas, Kevin L. |
|
2010 |
160 |
4 |
p. 744-751 8 p. |
article |
27 |
Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era
|
Lopez, John J. |
|
2010 |
160 |
4 |
p. 767-774.e1 6974 p. |
article |
28 |
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
|
Beygui, Farzin |
|
2010 |
160 |
4 |
p. 642-648.e1 5839 p. |
article |
29 |
Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation
|
Ino, Yasushi |
|
2010 |
160 |
4 |
p. 775.e1-775.e9 7.74999992251E11 p. |
article |
30 |
Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure
|
Rusconi, Paolo G. |
|
2010 |
160 |
4 |
p. 776-783 8 p. |
article |
31 |
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
|
White, Harvey |
|
2010 |
160 |
4 |
p. 655-661.e2 65446 p. |
article |
32 |
Table of Contents
|
|
|
2010 |
160 |
4 |
p. A1-A4 nvt p. |
article |
33 |
The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarction
|
Bates, Eric R. |
|
2010 |
160 |
4 |
p. 574-576 3 p. |
article |
34 |
Unified definition of clinical trials end points
|
Ghali, Jalal K. |
|
2010 |
160 |
4 |
p. e33- 1 p. |
article |